Director, Thrombosis Research, Division of Hematology, MGH
Massachusetts General Hospital and Harvard Medical School
Hematology
Boston, Massachusetts, United States
Dr. Rachel Rosovsky, MD, MPH, board-certified hematologist at Massachusetts General Hospital (MGH), provides clinical care full-time, supervises trainees and conducts research in area of thrombosis and hemostasis. She is Associate Professor of Medicine at Harvard Medical School (HMS), Director of Thrombosis Research in Division of Hematology at MGH, Co-Chair of MGH’s Thrombosis Committee, and Co-Chair of Thrombosis and Hemostasis Management Quality Collaborative for MassGeneralBrigham. She earned her undergraduate degree from University of Pennsylvania, medical degree from HMS and master’s in public health from Harvard School of Public Health. She completed residency at Brigham and Women's Hospital and fellowship at Dana Farber Cancer Institute/MGH. Dr. Rosovsky is one of the founders and Immediate Past President of The Pulmonary Embolism Response Team (PERT) ConsortiumTM. She also serves as the co-chair for American Heart Association VTE Committee and is an Associate Editor for the American Journal of Hematology. She is on Executive Committee for Venous thromboEmbolism Network US (VENUS), Committee on Quality for the American Society of Hematology (ASH), and Medical and Scientific Advisory Board for the Foundation for Women and Girls with Bleeding Disorders (FWGBD). Dr. Rosovsky collaborates with researchers worldwide, has published over 150 peer reviewed articles in this space, and has presented at numerous national and international conferences. She has sought to improve the care of patients with blood clots and advance the understanding and treatment of this medical condition for the past 20 years.
Disclosure information not submitted.
CURRENTS OF CARE: MEDICAL MANAGEMENT
Saturday, November 1, 2025
1:30pm - 2:30pm PT
Hypercoagulable Workup and Management Considerations After VTE—Beyond the Standard Lab Tests
Saturday, November 1, 2025
1:30pm - 1:38pm PT
Factor XIa Inhibition: What Gaps in Anticoagulation Therapy Will This Fill?
Saturday, November 1, 2025
1:46pm - 1:54pm PT
Sunday, November 2, 2025
9:00am - 10:00am PT
DVT in the Pediatric Population: When Should We Intervene?
Sunday, November 2, 2025
9:16am - 9:24am PT
Monday, November 3, 2025
8:00am - 9:00am PT
Pulmonary Embolism in Pregnancy: Interventional and Medical Management
Monday, November 3, 2025
8:14am - 8:21am PT
VIVA-PERT CONSORTIUM LATE-BREAKING DEEP DIVE
Monday, November 3, 2025
1:15pm - 2:00pm PT
STORM-PE RCT and Beyond: Emerging Clinical Data and CAVT Techniques | Funded by Penumbra, Inc.
Monday, November 3, 2025
12:00pm - 1:10pm PT